Arbutus Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Q2 total revenue of $10.7M includes previously-deferred revenue following reacquisition of Greater China rights to imdusiran

Dr. Roger Sawhney joins the Arbutus Board of Directors following resignation of Anuj Hasija

Read more at globenewswire.com